CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells

Cell Cycle

Volumn 12, Issue 19, 2013, Pages 3364-3372

  Walters, Denise K ^a   Arendt, Bonnie K ^a   Jelinek, Diane F ^a  

^a MAYO CLINIC   (United States)

Author keywords

CD147; Lactate; MCT1; MCT4; Multiple myeloma

Indexed keywords

CD147 ANTIGEN; LACTIC ACID; MESSENGER RNA; MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 4; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CD147; LACTATE; MCT1; MCT4; MULTIPLE MYELOMA;

ANTIGENS, CD147; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; LACTIC ACID; MONOCARBOXYLIC ACID TRANSPORTERS; MULTIPLE MYELOMA; MUSCLE PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SYMPORTERS; TUMOR CELLS, CULTURED;

EID: 84886712582     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.26193     Document Type: Article

References (36)

1. Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med 2004; 351:1860-73; PMID:15509819; http://dx.doi.org/10.1056/NEJMra041875
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58:71-96; PMID:18287387; http://dx.doi.org/10.3322/CA.2007.0010 (Pubitemid 351521864)
3. Kyle RA, Rajkumar SV. Monoclonal gammopathies of undetermined significance. Rev Clin Exp Hematol 2002; 6:225-52; PMID:12616697; http://dx.doi.org/10.1046/j.1468-0734.2002.00076.x (Pubitemid 35408172)
4. Chng WJ, Fonseca R. Genomics in multiple myeloma: biology and clinical implications. Pharmacogenomics 2005; 6:563-73; PMID:16142997; http://dx.doi.org/10.2217/14622416.6.6.563 (Pubitemid 41341623)
5. Bergsagel PL, Kuehl WM. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol 2005; 23:6333-8; PMID:16155016; http://dx.doi.org/10.1200/JCO.2005.05.021 (Pubitemid 46218843)
6. Arendt BK, Walters DK, Wu X, Tschumper RC, Huddleston PM, Henderson KJ, Dispenzieri A, Jelinek DF. Increased expression of extracellular matrix metalloproteinase inducer (CD147) in multiple myeloma: role in regulation of myeloma cell proliferation. Leukemia 2012; 26:2286-96; PMID:22460757; http://dx.doi.org/10.1038/leu.2012.91
7. Iacono KT, Brown AL, Greene MI, Saouaf SJ. CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Mol Pathol 2007; 83:283- 95; PMID:17945211; http://dx.doi.org/10.1016/j. yexmp.2007.08.014 (Pubitemid 350087035)
8. Kirk P, Wilson MC, Heddle C, Brown MH, Barclay AN, Halestrap AP. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J 2000; 19:3896- 904; PMID:10921872; http://dx.doi.org/10.1093/emboj/19.15.3896 (Pubitemid 30608530)
9. Halestrap AP. The monocarboxylate transporter family-Structure and functional characterization. IUBMB Life 2012; 64:1-9; PMID:22131303; http://dx.doi.org/10.1002/iub.573
10. Draoui N, Feron O. Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments. Dis Model Mech 2011; 4:727-32; PMID:22065843; http://dx.doi.org/10.1242/dmm.007724
11. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324:1029-33; PMID:19460998; http://dx.doi.org/10.1126/science.1160809
12. Kennedy KM, Dewhirst MW. Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation. Future Oncol 2010; 6:127-48; PMID:20021214; http://dx.doi.org/10.2217/fon.09.145
13. Durie BG, Waxman AD, D'Agnolo A, Williams CM. Whole-body (18)F-FDG PET identifies highrisk myeloma. J Nucl Med 2002; 43:1457-63; PMID:12411548 (Pubitemid 35285870)
14. Fujiwara S, Kawano Y, Yuki H, Okuno Y, Nosaka K, Mitsuya H, Hata H. PDK1 inhibition is a novel therapeutic target in multiple myeloma. Br J Cancer 2013; 108:170-8; PMID:23321518; http://dx.doi.org/10.1038/bjc.2012.527
15. Zhan F, Barlogie B, Arzoumanian V, Huang Y, Williams DR, Hollmig K, Pineda-Roman M, Tricot G, van Rhee F, Zangari M, et al. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood 2007; 109:1692-700; PMID:17023574; http://dx.doi.org/ 10.1182/blood-2006-07-037077 (Pubitemid 46239604)
16. Halestrap AP, Meredith D. The SLC16 gene familyfrom monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 2004; 447:619-28; PMID:12739169; http://dx.doi.org/10.1007/s00424-003-1067- 2 (Pubitemid 38241446)
17. Wilson MC, Meredith D, Halestrap AP. Fluorescence resonance energy transfer studies on the interaction between the lactate transporter MCT1 and CD147 provide information on the topology and stoichiometry of the complex in situ. J Biol Chem 2002; 277:3666-72; PMID:11719518; http://dx.doi.org/10.1074/ jbc.M109658200 (Pubitemid 34953240)
18. Le Floch R, Chiche J, Marchiq I, Naiken T, Ilc K, Murray CM, Critchlow SE, Roux D, Simon MP, Pouysségur J. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors. Proc Natl Acad Sci U S A 2011; 108:16663-8; PMID:21930917; http://dx.doi.org/10.1073/pnas.1106123108
19. Ho J, de Moura MB, Lin Y, Vincent G, Thorne S, Duncan LM, Hui-Min L, Kirkwood JM, Becker D, Van Houten B, et al. Importance of glycolysis and oxidative phosphorylation in advanced melanoma. Mol Cancer 2012; 11:76; PMID:23043612; http://dx.doi.org/10.1186/1476-4598-11-76
20. Pinheiro C, Albergaria A, Paredes J, Sousa B, Dufloth R, Vieira D, Schmitt F, Baltazar F. Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology 2010; 56:860-7; PMID:20636790; http://dx.doi.org/10.1111/j.1365-2559.2010.03560.x
21. Schneiderhan W, Scheler M, Holzmann KH, Marx M, Gschwend JE, Bucholz M, Gress TM, Seufferlein T, Adler G, Oswald F. CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models. Gut 2009; 58:1391-8; PMID:19505879; http://dx.doi.org/10. 1136/gut.2009.181412
22. Sonveaux P, Végran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF, et al. Targeting lactatefueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008; 118:3930-42; PMID:19033663
23. Miranda-Gonçalves V, Honavar M, Pinheiro C, Martinho O, Pires MM, Pinheiro C, Cordeiro M, Bebiano G, Costa P, Palmeirim I, et al. Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets. Neuro Oncol 2013; 15:172-88; PMID:23258846; http://dx.doi.org/10.1093/ neuonc/nos298
24. de Oliveira AT, Pinheiro C, Longatto-Filho A, Brito MJ, Martinho O, Matos D, Carvalho AL, Vazquez VL, Silva TB, Scapulatempo C, et al. Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs). J Bioenerg Biomembr 2012; 44:171- 8; PMID:22281667; http://dx.doi.org/10.1007/ s10863-012-9408-5
25. Pinheiro C, Longatto-Filho A, Azevedo-Silva J, Casal M, Schmitt FC, Baltazar F. Role of monocarboxylate transporters in human cancers: state of the art. J Bioenerg Biomembr 2012; 44:127- 39; PMID:22407107; http://dx.doi.org/10. 1007/s10863-012-9428-1
26. Dhup S, Dadhich RK, Porporato PE, Sonveaux P. Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis. Curr Pharm Des 2012; 18:1319-30; PMID:22360558; http://dx.doi.org/10.2174/138161212799504902
27. Boidot R, Végran F, Meulle A, Le Breton A, Dessy C, Sonveaux P, Lizard-Nacol S, Feron O. Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors. Cancer Res 2012; 72:939-48; PMID:22184616; http://dx.doi.org/10.1158/0008-5472.CAN-11- 2474
28. Gladden LB. Lactate metabolism: a new paradigm for the third millennium. J Physiol 2004; 558:5- 30; PMID:15131240; http://dx.doi.org/10.1113/jphysiol. 2003.058701 (Pubitemid 39077388)
29. Broyl A, Hose D, Lokhorst H, de Knegt Y, Peeters J, Jauch A, Bertsch U, Buijs A, Stevens-Kroef M, Beverloo HB, et al. Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients. Blood 2010; 116:2543- 53; PMID:20574050; http://dx.doi.org/10.1182/blood-2009-12- 261032
30. Izumi H, Takahashi M, Uramoto H, Nakayama Y, Oyama T, Wang KY, Sasaguri Y, Nishizawa S, Kohno K. Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells. Cancer Sci 2011; 102:1007-13; PMID:21306479; http://dx.doi.org/10.1111/j.1349-7006.2011.01908.x
31. Ovens MJ, Davies AJ, Wilson MC, Murray CM, Halestrap AP. AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10. Biochem J 2010; 425:523- 30; PMID:19929853; http://dx.doi.org/10.1042/BJ20091515
32. Walters DK, Wu X, Tschumper RC, Arendt BK, Huddleston PM, Henderson KJ, Dispenzieri A, Jelinek DF. Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX. Leukemia 2011; 25:1344- 53; PMID:21566653; http://dx.doi.org/10.1038/leu.2011.94
33. Westendorf JJ, Ahmann GJ, Greipp PR, Witzig TE, Lust JA, Jelinek DF. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6. Leukemia 1996; 10:866-76; PMID:8656685 (Pubitemid 26168407)
34. Jelinek DF, Ahmann GJ, Greipp PR, Jalal SM, Westendorf JJ, Katzmann JA, Kyle RA, Lust JA. Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications. Cancer Res 1993; 53:5320-7; PMID:8221668 (Pubitemid 23333406)
35. Arendt BK, Ramirez-Alvarado M, Sikkink LA, Keats JJ, Ahmann GJ, Dispenzieri A, Fonseca R, Ketterling RP, Knudson RA, Mulvihill EM, et al. Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2. Blood 2008; 112:1931- 41; PMID:18567838; http://dx.doi.org/10.1182/blood-2008-03-143040
36. Walters DK, French JD, Arendt BK, Jelinek DF. Atypical expression of ErbB3 in myeloma cells: cross-talk between ErbB3 and the interferon-alpha signaling complex. Oncogene 2003; 22:3598- 607; PMID:12789268; http://dx.doi.org/10.1038/sj.onc.1206512 (Pubitemid 36765319)